1. Home
  2. XENE vs HAFN Comparison

XENE vs HAFN Comparison

Compare XENE & HAFN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XENE
  • HAFN
  • Stock Information
  • Founded
  • XENE 1996
  • HAFN 2012
  • Country
  • XENE Canada
  • HAFN Singapore
  • Employees
  • XENE N/A
  • HAFN N/A
  • Industry
  • XENE Biotechnology: Pharmaceutical Preparations
  • HAFN
  • Sector
  • XENE Health Care
  • HAFN
  • Exchange
  • XENE Nasdaq
  • HAFN Nasdaq
  • Market Cap
  • XENE 2.5B
  • HAFN 2.7B
  • IPO Year
  • XENE 2014
  • HAFN N/A
  • Fundamental
  • Price
  • XENE $28.85
  • HAFN $5.06
  • Analyst Decision
  • XENE Strong Buy
  • HAFN Strong Buy
  • Analyst Count
  • XENE 11
  • HAFN 1
  • Target Price
  • XENE $54.82
  • HAFN $6.50
  • AVG Volume (30 Days)
  • XENE 1.5M
  • HAFN 1.6M
  • Earning Date
  • XENE 05-12-2025
  • HAFN 05-15-2025
  • Dividend Yield
  • XENE N/A
  • HAFN 18.08%
  • EPS Growth
  • XENE N/A
  • HAFN N/A
  • EPS
  • XENE N/A
  • HAFN 1.20
  • Revenue
  • XENE $7,500,000.00
  • HAFN $2,631,664,000.00
  • Revenue This Year
  • XENE N/A
  • HAFN N/A
  • Revenue Next Year
  • XENE $611.23
  • HAFN $1.88
  • P/E Ratio
  • XENE N/A
  • HAFN $4.07
  • Revenue Growth
  • XENE N/A
  • HAFN N/A
  • 52 Week Low
  • XENE $26.74
  • HAFN $3.61
  • 52 Week High
  • XENE $46.00
  • HAFN $8.99
  • Technical
  • Relative Strength Index (RSI)
  • XENE 34.31
  • HAFN N/A
  • Support Level
  • XENE $29.38
  • HAFN N/A
  • Resistance Level
  • XENE $31.74
  • HAFN N/A
  • Average True Range (ATR)
  • XENE 1.34
  • HAFN 0.00
  • MACD
  • XENE -0.31
  • HAFN 0.00
  • Stochastic Oscillator
  • XENE 7.53
  • HAFN 0.00

About XENE Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.

About HAFN Hafnia Limited Common Shares

Hafnia Ltd is one of the tanker owners, transporting oil, oil products and chemicals for national and international oil companies, chemical companies, as well as trading and utility companies. As owners and operators of around 200 vessels, It offers a fully integrated shipping platform, including technical management, commercial and chartering services, pool management, and a large-scale bunker procurement desk.

Share on Social Networks: